Short-term adenosine monophosphate-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside treatment increases the sirtuin 1 protein expression in skeletal muscle

Metabolism: Clinical and Experimental

Volumn 60, Issue 3, 2011, Pages 394-403

  Suwa, Masataka ^a   Nakano, Hiroshi ^b   Radak, Zsolt ^c   Kumagai, Shuzo ^d  

^a TOHOKU INSTITUTE OF TECHNOLOGY   (Japan)

^b NAKAMURA GAKUEN UNIVERSITY   (Japan)

^c UNIVERSITY OF PHYSICAL EDUCATION   (Hungary)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; ACETYL COENZYME A CARBOXYLASE; ADENYLATE KINASE; FAT; GLUCOSE; GLUCOSE TRANSPORTER 4; HEXOKINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; SERINE; SIRTUIN; THREONINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EXTENSOR DIGITORUM LONGUS MUSCLE; FAST MUSCLE; FATTY ACID METABOLISM; GLUCOSE METABOLISM; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; SLOW MUSCLE; SOLEUS MUSCLE;

ACETYL-COA CARBOXYLASE; AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; ENZYME ACTIVATION; GLUCOSE TRANSPORTER TYPE 4; HEXOKINASE; HYPOGLYCEMIC AGENTS; MALE; MUSCLE, SKELETAL; PHOSPHORYLATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; RIBONUCLEOTIDES; RNA-BINDING PROTEINS; SIRTUIN 1; TRANSCRIPTION FACTORS;

EID: 79951805107     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2010.03.003     Document Type: Article

References (62)

1. Tissenbaum HA, Guarente L. Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 2001;410:227-30. (Pubitemid 32216597)
2. Kaeberlein M, McVey M, Guarente L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev 1999;13:2570-80. (Pubitemid 29489648)
3. Blander G, Guarente L. The Sir2 family of protein deacetylases. Annu Rev Biochem 2004;73:417-35. (Pubitemid 39050375)
4. Fulco M, Sartorelli V. Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues. Cell Cycle 2008;7:3669-79.
5. Sun C, Zhang F, Ge X, et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. Cell Metab 2007;6:307-19. (Pubitemid 47468091)
6. Baur JA, Pearson KJ, Price NL, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-42.
7. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 α. Cell 2006;127:1109-22. (Pubitemid 44894520)
8. Rodgers JT, Lerin C, Haas W, et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1. Nature 2005;434:113-8. (Pubitemid 40349395)
9. Gerhart-Hines Z, Rodgers JT, Bare O, et al. Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1 α. EMBO J 2007;26:1913-23. (Pubitemid 46624046)
10. Winder WW. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 2002;91:1017-28.
11. Woods A, Cheung PC, Smith FC, et al. Characterization of AMP-activated protein kinase β and γ subunits. Assembly of the heterotrimeric complex in vitro. J Biol Chem 1996;26:10282-90.
12. Polekhina G, Gupta A, Michell BJ, et al. AMPK β subunit targets metabolic stress sensing to glycogen. Curr Biol 2003;13:867-71. (Pubitemid 36573256)
13. Adams J, Chen ZP, Van Denderen BJ, et al. Intrasteric control of AMPK via the gamma1 subunit AMP allosteric regulatory site. Protein Sci 2004;13:155-65. (Pubitemid 38021150)
14. Stein SC, Woods A, Jones NA, et al. The regulation of AMP-activated protein kinase by phosphorylation. Biochem J 2000;345:437-43. (Pubitemid 30099070)
15. Sakamoto K, McCarthy A, Smith D, et al. Deficiency of LKB1 in skeletal muscle prevents AMPK activation and glucose uptake during contraction. EMBO J 2005;24:1810-20. (Pubitemid 40769500)
16. Fujii N, Hayashi T, Hirshman MF, et al. Exercise induces isoform-specific increase in 5′AMP-activated protein kinase activity in human skeletal muscle. Biochem Biophys Res Commun 2000;273:1150-5. (Pubitemid 30481094)
17. Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 2002;415:339-43. (Pubitemid 34087557)
18. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 2002;8:1288-95. (Pubitemid 35373562)
19. Zhou G, Myers R, Li Y, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001;108:1167-74. (Pubitemid 32995375)
20. Suwa M, Egashira T, Nakano H, et al. Metformin increases the PGC-1α protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo. J Appl Physiol 2006;101:1685-92. (Pubitemid 44904490)
21. Merrill GF, Kurth EJ, Hardie DG, et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol Endocrinol Metab 1997;273:E1107-12.
22. Jessen N, Pold R, Buhl ES, et al. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles. J Appl Physiol 2003;94:1373-9. (Pubitemid 36348812)
23. Suwa M, Nakano H, Kumagai S. Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles. J Appl Physiol 2003;95:960-8. (Pubitemid 37033988)
24. Winder WW, Holmes BF, Rubink DS, et al. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 2000;88:2219-26. (Pubitemid 30453931)
25. Leone TC, Lehman JJ, Finck BN, et al. PGC-1α deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 2005;3:e101.
26. Lin J, Wu H, Tarr PT, et al. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 2002;418:797-801.
27. Lan F, Cacicedo JM, Ruderman N, et al. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008;283:27628-35.
28. Fulco M, Cen Y, Zhao P, et al. Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. Dev Cell 2008;14:661-73. (Pubitemid 351622608)
29. Suwa M, Nakano H, Radak Z, et al. Endurance exercise increases the SIRT1 and peroxisome proliferator-activated receptor γ coactivator-1α protein expressions in rat skeletal muscle. Metabolism 2008;57:986-98. (Pubitemid 351814692)
30. Ferrara N, Rinaldi B, Corbi G, et al. Exercise training promotes SIRT1 activity in aged rats. Rejuvenation Res 2008;11:139-50. (Pubitemid 351271626)
31. Booth FW, Baldwin KM. Muscle plasticity: energy demand and supply processes. In: Rowell L, Sheperd J, editors. Handbook of physiology. Exercise: regulation and integration of multiple systems. Bethesda, MD: Am Physiol Soc; 1996. p. 1075-123.
32. Suchankova G, Nelson LE, Gerhart-Hines Z, et al. Concurrent regulation of AMP-activated protein kinase and SIRT1 in mammalian cells. Biochem Biophys Res Commun 2009;378:836-41.
33. Jørgensen SB, Treebak JT, Viollet B, et al. Role of AMPKα2 in basal, training-, and AICAR-induced GLUT4, hexokinase II, and mitochondrial protein expression in mouse muscle. Am J Physiol Endocrinol Metab 2007;292:E331-E339. (Pubitemid 46052958)
34. Dzamko N, Schertzer JD, Ryall JG, et al. AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J Physiol 2008;586:5819-31.
35. 2-AMPK activity is not essential for an increase in fatty acid oxidation during low-intensity exercise. Am J Physiol Endocrinol Metab 2009;296:E47-E55.
36. Fryer LG, Hajduch E, Rencurel F, et al. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes 2000;49:1978-85.
37. Davis BJ, Xie Z, Viollet B, et al. Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006;55:496-505. (Pubitemid 43343281)
38. Ota H, Eto M, Kano MR, et al. Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler Thromb Vasc Biol 2008;28:1634-9.
39. Nisoli E, Tonello C, Cardile A, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005;310:314-7. (Pubitemid 41457197)
40. Higaki Y, Hirshman MF, Fujii N, et al. Nitric oxide increases glucose uptake through a mechanism that is distinct from the insulin and contraction pathways in rat skeletal muscle. Diabetes 2001;50:241-7. (Pubitemid 32127278)
41. Stephens TJ, Canny BJ, Snow RJ, et al. 5′-Aminoimidazole-4- carboxyamide-ribonucleoside-activated glucose transport is not prevented by nitric oxide synthase inhibition in rat isolated skeletal muscle. Clin Exp Pharmacol Physiol 2004;31:419-23. (Pubitemid 39044120)
42. Delp MD, Duan C. Composition and size of type I, IIA, IID/X, and IIB fibers and citrate synthase activity of rat muscle. J Appl Physiol 1996;80:261-70. (Pubitemid 26034871)
43. Mahlapuu M, Johansson C, Lindgren K, et al. Expression profiling of the γ-subunit isoforms of AMP-activated protein kinase suggests a major role for γ3 in white skeletal muscle. Am J Physiol Endocrinol Metab 2004;286:E194-E200. (Pubitemid 38140309)
44. Röckl KS, Hirshman MF, Brandauer J, et al. Skeletal muscle adaptation to exercise training: AMP-activated protein kinase mediates muscle fiber type shift. Diabetes 2007;56:2062-9. (Pubitemid 47195818)
45. Mu J, Brozinick Jr JT, Valladares O, et al. A role for AMP-activated protein kinase in contraction- and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 2001;7:1085-94. (Pubitemid 32525754)
46. Garcia-Roves PM, Osler ME, Holmström MH, et al. Gain-of-function R225Q mutation in AMP-activated protein kinase γ3 subunit increases mitochondrial biogenesis in glycolytic skeletal muscle. J Biol Chem 2008;283:35724-34.
47. Gurd B, Yoshida Y, Lally J, et al. SIRT1 is not associated with oxidative capacity in rat heart and skeletal muscle and its overexpression reduces mitochondrial biogenesis. J Physiol 2009;587:1817-28.
48. Zschoernig B, Mahlknecht U. SIRTUIN 1: regulating the regulator. Biochem Biophys Res Commun 2008;376:251-5.
49. Chen WY, Wang DH, Yen RC, et al. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 2005;123:437-48. (Pubitemid 41546674)
50. Wang C, Chen L, Hou X, et al. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol 2006;8:1025-31. (Pubitemid 44314735)
51. Kraniou GN, Cameron-Smith D, Hargreaves M. Acute exercise and GLUT4 expression in human skeletal muscle: influence of exercise intensity. J Appl Physiol 2006;101:934-7. (Pubitemid 44352310)
52. O'Doherty RM, Bracy DP, Osawa H, et al. Rat skeletal muscle hexokinase II mRNA and activity are increased by a single bout of acute exercise. Am J Physiol Endocrinol Metab 1994;266:E171-E178.
53. Mathai AS, Bonen A, Benton CR, et al. Rapid exercise-induced changes in PGC-1α mRNA and protein in human skeletal muscle. J Appl Physiol 2008;105:1098-105.
54. Osawa H, Robey RB, Printz RL, et al. Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II gene. J Biol Chem 1996;271:17296-303. (Pubitemid 26244288)
55. Thomson DM, Herway ST, Fillmore N, et al. AMP-activated protein kinase phosphorylates transcription factors of the CREB family. J Appl Physiol 2008;104:429-38. (Pubitemid 351231489)
56. Herzig S, Long F, Jhala US, et al. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 2001;413:179-83. (Pubitemid 32867880)
57. Oshel KM, Knight JB, Cao KT, et al. Identification of a 30-base pair regulatory element and novel DNA binding protein that regulates the human GLUT4 promoter in transgenic mice. J Biol Chem 2000;275:23666-73. (Pubitemid 30624651)
58. Thai MV, Guruswamy S, Cao KT, et al. Myocyte enhancer factor 2 (MEF2)-binding site is required for GLUT4 gene expression in transgenic mice. Regulation of MEF2 DNA binding activity in insulin-deficient diabetes. J Biol Chem 1998;273:14285-92. (Pubitemid 28319143)
59. Holmes BF, Sparling DP, Olson AL, et al. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am J Physiol Endocrinol Metab 2005;289:E1071-6.
60. Bordone L, Motta MC, Picard F, et al. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic β cells. PLoS Biol 2006;4:e31.
61. Qiang L, Wang H, Farmer SR. Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L α. Mol Cell Biol 2007;27:4698-707. (Pubitemid 47016124)
62. Kim D, Nguyen MD, Dobbin MM, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 2007;26:3169-79. (Pubitemid 47057498)